Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Biologics Outsourcing Market Growth in 2025?

In recent years, the biologics outsourcing market has seen substantial growth. It’s projected to expand from $20.06 billion in 2024 to $22.7 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.2%. Factors such as rising R&D expenses, regulatory pressure, the need for specialized expertise, and globalization are responsible for the growth during this historical period.

What Is the Forecast for the Biologics Outsourcing Market Size Through 2029?

In the coming years, the biologics outsourcing market is anticipated to witness significant expansion. The market is forecasted to escalate to a value of $37.52 billion in 2029, with a compound annual growth rate (CAGR) of 13.4%. This predicted advancement during the forecast period can be accredited to the growth of emerging markets, the rise of personalized medicine, strategic partnerships, and the expiration of biological drug patents. Notable trends during the forecast period encompass technological advancements, escalation in outsourcing complexity, expansion of the biosimilars market, integration of data analytics, and resilience in the supply chain.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12573&type=smp

What are the Key Market Players in Biologics Outsourcing Market and How They’re Evolving?

Major companies operating in the biologics outsourcing market include AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Lonza Group Ag, Catalent Inc., Sartorius Stedim Biotech S.A., Charles River Laboratories International Inc., WuXi Biologics Inc., Samsung Biologics Co. Ltd., Emergent BioSolutions Inc., CordenPharma GmbH, Ajinomoto Bio-Pharma Services, Syngene International Limited, Rentschler Biopharma SE, Albany Molecular Research Inc., KBI Biopharma Inc., Fujifilm Diosynth Biotechnologies Inc., Avid Bioservices Inc., BioVectra Inc., ProBioGen AG, ABL Inc., Vibalogics GmbH, JHL Biotech Inc., Goodwin Biotechnology Inc., Crown Bioscience Inc., Cytovance Biologics Inc., LakePharma Inc., AGC Biologics GmbH, Biomay AG, Polpharma Biologics S.A.

What Are the Primary Growth Drivers in the Biologics Outsourcing Market?

The escalation in cancer incidences is anticipated to fuel the progression of the biologics outsourcing market. Cancer, a generic term for a diverse range of diseases, can occur in nearly any body part or organ when abnormal cells multiply uncontrollably and infiltrate into other body parts or organs, exceeding their usual boundaries. The biologics outsourcing industry plays an essential role in handling cancer by offering specialised expertise, resources and infrastructure for the crafting, production, and clinical distribution of biological therapies — inclusive of monoclonal antibodies, immunotherapies, along with other targeted biologics utilised for diagnosing, treating, and managing various forms of cancer. For example, as per the US-based intergovernmental organization National Center for Biotechnology Information’s report in January 2023, there were 1,958,310 fresh cancer incidences in the United States, and a projection of 609,820 cancer mortalities to occur in 2023. Moreover, the annual number of new cancer cases is predicted to escalate to 29.5 million, and cancer-related mortalities to reach 16.4 million by 2040. Consequently, the upsurge in cancer incidences is charging the growth of the biologics outsourcing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12573&type=smp

What Are the Leading Segments in the Global Biologics Outsourcing Industry?

The biologics outsourcing market covered in this report is segmented –

1) By Product Type: Antibodies, Recombinant, Vaccines, Protein, Other Products

2) By Source: Human, Microbial, Other Source

3) By Application: Oncology, Cellular And Gene Therapy, Blood And Blood-Related Products Development, Vaccine Development, Stem Cell Research, Other Applications

4) By End User: Pharmaceutical Industries, Biotechnology Industries, Contract Development And Manufacturing Organization(CDMO)

Subsegments:

1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies

2) By Recombinant: Recombinant Proteins, Recombinant DNA Products

3) By Vaccines: Therapeutic Vaccines, Preventive Vaccines

4) By Protein: Enzymes, Hormones, Cytokines

5) By Other Products: Gene Therapies, Cell Therapies, Biosimilars

What Are the Key Market Trends in the Biologics Outsourcing Industry?

The rise in advancements in biologics is a significant trend being observed in the biologics outsourcing market. Top-tier companies that are part of this sector are harnessing novel technologies to maintain their market standing. For example, in February 2022, US-based firms Abzena and Alira Health, along with the French biopharmaceutical company Oncodesign, introduced DRIVE-Biologics. This consortium is devoted to biologic drug discovery and developmental programs, providing comprehensive solutions and niche services ranging from biological discovery to clinical and commercial manufacturing. This collaborative venture merges expertise in various sectors like design, preclinical proof of concept, pharmaco-imaging, toxicology, and clinical design through commercial production, striving to enhance information distribution and project delivery while minimizing the risks involved in biologics development. Furthermore, the partners get exposure to expertise across various stages of drug discovery and development, including design, preclinical, clinical, and CMC stages.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/biologics-outsourcing-global-market-report

What Is the Regional Outlook for the Biologics Outsourcing Market?

North America was the largest region in the biologics outsourcing market in 2024. The regions covered in the biologics outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12573

This Report Delivers Insight On:

1. How big is the biologics outsourcing market, and how is it changing globally?

2. Who are the major companies in the biologics outsourcing market, and how are they performing?

3. What are the key opportunities and risks in the biologics outsourcing market right now?

4. Which products or customer segments are growing the most in the biologics outsourcing market?

5. What factors are helping or slowing down the growth of the biologics outsourcing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model